Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trials

BACKGROUND: An abnormal increase of contrast-enhancing lesion (CEL) counts on frequent MRIs is interpreted as a signal of potential worsening in multiple sclerosis (MS) clinical trials. We demonstrate the utility of the MR personalized activity index (MR-pax) to identify such increases. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yinshan, Kondo, Yumi, Traboulsee, Anthony, Li, David KB, Riddehough, Andrew, Petkau, A John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433340/
https://www.ncbi.nlm.nih.gov/pubmed/28607690
http://dx.doi.org/10.1177/2055217315577829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433340/
https://www.ncbi.nlm.nih.gov/pubmed/28607690
http://dx.doi.org/10.1177/2055217315577829

Ejemplares similares